Renal function-based contrast dosing reduces nephropathy risk

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1368, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contrast Nephropathy: An Evidence-Based Approach to Prevention

By Kandzari D.E. Rebeiz A.G. Wang A. Sketch M.H.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 6, 2003-01 ,pp. : 395-405

Adis International

Access to resources Recommend Favorite

Renal Function, Peak Anti‐Xa Levels and Enoxaparin Dosing

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 1, 2004-03 ,pp. : 14-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urinary Alkalinisation with Oral Sodium Bicarbonate for Patients at Risk of Contrast‐Induced Nephropathy

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 2, 2012-06 ,pp. : 118-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sirolimus reduces cancer risk after renal transplant

Reactions Weekly, Vol. 1, Iss. 1079, 2005-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Ciclosporin reduces risk of diabetes following renal transplantation

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite